Atlas Trials

Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia Subjects

Clinical trial NCT05541939 · COMPLETED

Trial details

NCT number
NCT05541939
Sponsor
Vogenx, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Postbariatric Hypoglycemia
Start date
2022-09-13
Primary completion
2023-02-17
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.